Effect of Bosentan on Endothelial Function in Patients With Type 2 Diabetes

PHASE2CompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

April 30, 2010

Study Completion Date

January 31, 2011

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

Bosentan

62.5 mg bid for two weeks and 125 mg bid for two weeks

DRUG

Placebo

Matched placebo bid

Trial Locations (1)

17176

Karolinska Institutet, Karolinska University Hospital, Stockholm

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Swedish Heart Lung Foundation

OTHER

collaborator

The Swedish Research Council

OTHER_GOV

collaborator

Actelion

INDUSTRY

lead

Karolinska Institutet

OTHER

NCT01357109 - Effect of Bosentan on Endothelial Function in Patients With Type 2 Diabetes | Biotech Hunter | Biotech Hunter